Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Franz

Showing results (131-140 of 181) with videos related to

Pageof 19
Sort By:
Wiener Klinische Wochenschrift|May 10, 2019
Real-world extravascular lung water index measurements in critically ill patients : Pulse index continuous cardiac output measurements: time course analysis and association with clinical characteristicsMatthias Werner, Bernhard Wernly, Michael Lichtenauer, et al.
International Journal of Cardiology|September 4, 2013
Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B⁺ tenascin-C and ED-A⁺ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosisMarcus Franz, Alexander Berndt, Dario Neri, et al.
Minerva Medica|April 14, 2018
Analysis of novel cardiovascular biomarkers in patients with peripheral artery diseasePeter Jirak, Moritz Mirna, Bernhard Wernly, et al.
Cardiovascular Research|July 18, 2024
Extra domain A-containing fibronectin in pulmonary hypertension and treatment effects of a function-blocking antibodyIsabell Singerer, Laura Tempel, Katja Gruen, et al.
International Journal of Cardiology|June 10, 2015
Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectinMarcus Franz, Fabia Doll, Katja Grün, et al.
International Journal of Molecular Sciences|November 13, 2021
Long-Chain and Very Long-Chain Ceramides Mediate Doxorubicin-Induced Toxicity and FibrosisTom Kretzschmar, Mohamed M Bekhite, Jasmine M F Wu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 25, 2013
Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectinMarcus Franz, Ingrid Hilger, Katja Grün, et al.
European Journal of Clinical Investigation|November 15, 2022
Targeted Interleukin-9 delivery in pulmonary hypertension: Comparison of immunocytokine formats and effector cell studyJudith Heiss, Katja Grün, Laura Tempel, et al.
Zeitschrift Fur Rheumatologie|October 17, 2023
[Is JAK inhibition an option in the treatment of interstitial lung disease in rheumatoid arthritis?]Tobias Hoffmann, Ulf Teichgräber, Bianca Lassen-Schmidt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 12, 2019
Aortic annulus measurement with computed tomography angiography reduces aortic regurgitation after transfemoral aortic valve replacement compared to 3-D echocardiography: a single-centre experienceNadja Wystub, Laura Bäz, Sven Möbius-Winkler, et al.
Pageof 19

Showing results (131-140 of 181) with videos related to

Sort By:
Pageof 19
Wiener Klinische Wochenschrift|May 10, 2019
Real-world extravascular lung water index measurements in critically ill patients : Pulse index continuous cardiac output measurements: time course analysis and association with clinical characteristicsMatthias Werner, Bernhard Wernly, Michael Lichtenauer, et al.
International Journal of Cardiology|September 4, 2013
Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B⁺ tenascin-C and ED-A⁺ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosisMarcus Franz, Alexander Berndt, Dario Neri, et al.
Minerva Medica|April 14, 2018
Analysis of novel cardiovascular biomarkers in patients with peripheral artery diseasePeter Jirak, Moritz Mirna, Bernhard Wernly, et al.
Cardiovascular Research|July 18, 2024
Extra domain A-containing fibronectin in pulmonary hypertension and treatment effects of a function-blocking antibodyIsabell Singerer, Laura Tempel, Katja Gruen, et al.
International Journal of Cardiology|June 10, 2015
Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectinMarcus Franz, Fabia Doll, Katja Grün, et al.
International Journal of Molecular Sciences|November 13, 2021
Long-Chain and Very Long-Chain Ceramides Mediate Doxorubicin-Induced Toxicity and FibrosisTom Kretzschmar, Mohamed M Bekhite, Jasmine M F Wu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 25, 2013
Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectinMarcus Franz, Ingrid Hilger, Katja Grün, et al.
European Journal of Clinical Investigation|November 15, 2022
Targeted Interleukin-9 delivery in pulmonary hypertension: Comparison of immunocytokine formats and effector cell studyJudith Heiss, Katja Grün, Laura Tempel, et al.
Zeitschrift Fur Rheumatologie|October 17, 2023
[Is JAK inhibition an option in the treatment of interstitial lung disease in rheumatoid arthritis?]Tobias Hoffmann, Ulf Teichgräber, Bianca Lassen-Schmidt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 12, 2019
Aortic annulus measurement with computed tomography angiography reduces aortic regurgitation after transfemoral aortic valve replacement compared to 3-D echocardiography: a single-centre experienceNadja Wystub, Laura Bäz, Sven Möbius-Winkler, et al.
Pageof 19